CME Group's upcoming Q3 2026 earnings release on October 21 features consensus estimates for EPS near $2.94–$2.96 and revenue around $1.69–$1.79 billion, reflecting year-over-year growth of roughly 10%. Record average daily volumes, including a 22% September increase and 16% quarterly rise driven by interest-rate and foreign-exchange activity, represent the main catalyst supporting the 62.5% market-implied probability of an earnings beat. Persistent strength in market-data revenue, new product launches such as expanded crypto derivatives, and a history of beating estimates in 76% of recent quarters bolster trader sentiment. However, elevated forward valuations and already-high expectations for volumes and margins introduce uncertainty around potential upside surprises.